Wnt can specifically attenuate anti-tumor immunity by decreasing the expression of CCL4, which is a potent chemoattractant, thus preventing the recruitment of DCs and T cells to the TME and blocking adaptive anti-tumor immunity [38]. The gene discussed is CCL4; the disease is neoplasm.